Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using bioinformatics and computational tools-Reference-Cited by-同舟云学术

Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using bioinformatics and computational tools

Published:2018-07 Issue: Volume:98 Page:168-177
ISSN:0010-4825
Container-title:Computers in Biology and Medicine
language:en
Short-container-title:Computers in Biology and Medicine

Author:

Lawal Maryam,Olotu Fisayo A.,Soliman Mahmoud E.S.

Funder

School of Health Science

University of KwaZulu-Natal

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference80 articles.

1. Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular- streptozotocin in rat model;Khan;Neurochem. Int.,2012

2. disease: a di of cortical cholinergic innervation;Joseph;Science,1983

3. Protein Tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease;Crespo-Biel;Int. J. Alzheimer's Dis.,2012

4. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications;Hensley;Mol. Neurobiol.,2011

5. Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development?;Soutar;Curr. Alzheimer Res.,2009

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of terpenes rich Hura crepitans extract on glucose regulation and diabetic complications in STZ-induced diabetic rats;Biomedicine & Pharmacotherapy;2024-10

2. Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs);Current Neuropharmacology;2024-05

3. Neuroprotection induced by honey compounds;Natural Molecules in Neuroprotection and Neurotoxicity;2024

4. Serotonin receptors - a potential target for the treatment of Alzheimer’s disease;Биохимия;2023-12-15

5. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer’s Disease;Current Pharmaceutical Design;2023-12